A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH
A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH
复制标题
DOI:
10.1016/j.neurobiolaging.2011.02.023
复制
发表时间:
2012-08-01
影响因子:
4.2
通讯作者:
Hashimoto, Yasuhiro
中科院分区:
文献类型:
--
作者:
Futakawa, Satoshi;Nara, Kiyomitsu;Hashimoto, Yasuhiro
Idiopathic normal pressure hydrocephalus (iNPH) is an elderly dementia caused by abnormal metabolism in the cerebrospinal fluid (CSF). The tap test is the current basis for confirming iNPH, but it shows very low sensitivity, indicating that many patients who might be cured by a shunt operation will be missed. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, we found two transferrin isoforms: one had a unique N-glycan (Tf-1) whereas the other had N-glycan similar to that of serum transferrin (Tf-2). Glycan analyses revealed that Tf-1 had branching (biantennary) asialo- and agalacto-complex type N-glycans (N-acetylglucosamine [GlcNAc]-terminated glycans), which carried bisecting beta 1,4-N-acetylglucosamine and core alpha 1,6-fucose. To examine glycoform whether changes in iNPH, we introduced the Tf-2/Tf-1 ratio as a diagnostic index, which minimized blot-to-blot variations in measurement. The Tf-2/Tf-1 ratios of iNPH patients are significantly higher than those of controls (p = 0.0019) and Alzheimer's patients (p = 0.0010). This suggests that the Tf-2/Tf-1 ratio could distinguish iNPH from Alzheimer's disease, and possibly other dementias. In conclusion, glycoform analysis has diagnostic potential in neurological diseases. (C) 2012 Published by Elsevier Inc.